Why Nephrologists Get Sued: Delayed Dialysis, Fatal Potassium, and Dialysis-Access Complications

By John Mahoney · June 2026 · 8 min read

Nephrology is one of the lowest-frequency specialties for malpractice claims — low enough that it presents a data problem for anyone trying to screen these cases. In the landmark closed-claims dataset, nephrology fell below the reporting threshold, with fewer than 30 indemnity payments, so its frequency and severity figures are inferred from internal-medicine analogues and a small number of jurisdiction-specific studies rather than measured directly. The practical consequence: the patterns below are well-supported directionally, but the precise percentages and dollar figures are softer than for high-volume specialties and should be treated as such.

This guide is for plaintiff and defense med-mal attorneys evaluating nephrology matters. It covers the frequency-versus-severity picture, the diagnosis-and-management allegation profile, the catastrophic scenarios that drive these claims, the contributing factors, the co-defendant dynamic that inflates apparent involvement, and what separates a strong case from a weak one — with appropriate caution given the thin data.

Disclaimer: This article is for informational purposes only and does not constitute legal advice. The nephrology claim data is limited and partly inferred from related specialties and non-US studies; figures here are directional and should be independently verified before use in any matter.

Low Frequency, Catastrophic Outcomes, Thin Data

As an internal-medicine subspecialty, nephrology's profile is generally taken to track internal medicine — reported in the range of a 5–8% annual claim probability, and nephrologists reportedly carry comparatively low malpractice premiums. But the cases that do arise tend to be catastrophic. In one dialysis- and access-litigation study, death was reported in roughly 59% of cases; other outcomes include end-stage renal disease, lifelong dialysis dependence, and neurologic injury from electrolyte derangement. Multimillion-dollar verdicts have been cited (figures such as $10 million and $1.25 million appear in the literature), but these are individual examples, not a severity distribution, and the all-specialty mean indemnity figure in the underlying dataset was around $275,000.

One structural caveat matters more in nephrology than almost anywhere else: nephrologists are frequently named as co-defendants in inpatient acute-kidney-injury and dialysis cases even when the primary error is upstream — with the hospitalist, the intensivist, or the primary-care physician. This inflates the apparent frequency of nephrologist involvement and means a careful screen has to ask whether the nephrologist actually owned the decision at issue or was simply in the room.

The Allegation Profile

The reported nephrology allegations mirror the internal-medicine subspecialty pattern, weighted toward cognitive and management failures with a procedural tail:

• Diagnosis-related — delayed, missed, or failure to diagnose: failure to work up proteinuria, hematuria, or AKI and CKD progression. This is the dominant category, consistent with internal-medicine subspecialties where roughly a third to nearly half of claims are reported as diagnosis-related.
• Improper management of treatment or clinical course — delayed or mismanaged dialysis, AKI and electrolyte management, ESRD care.
• Procedural and performance error — vascular access and central venous catheter complications. In the reported dialysis-access study, performance error was cited in roughly 58% of disputes, with CVC issues a large share.
• Medication-related — renal-dose adjustment errors, nephrotoxic agents, and drug interactions in CKD and dialysis patients.
• Failure to monitor or act on abnormal labs — rising potassium, proteinuria — and failure to refer.

The Cannot-Miss Scenarios

A handful of fact patterns recur and should elevate merit and exposure on intake:

• Delayed or withheld dialysis leading to fatal hyperkalemia. This is the recurrent high-value nephrology scenario — a patient with a critically high potassium where dialysis or aggressive treatment was deferred, ending in a fatal arrhythmia. The cited large verdicts cluster here.
• Failure to diagnose or work up acute kidney injury and progressive chronic kidney disease.
• Failure to act on abnormal labs — untreated proteinuria or hematuria, a missed declining eGFR.
• Vascular access and hemodialysis catheter complications — placement injury, infection, bleeding. CVC complications are reported as a leading driver of access-related deaths.
• Intradialytic complications — hypotension and electrolyte or fluid mismanagement during or around dialysis; the reported data places most access complications in the pre- and post-dialysis window.
• Renal medication dosing errors and nephrotoxic exposure in CKD and dialysis patients.
• Delayed referral to nephrology by primary care, contributing to progression to ESRD — though here the upstream provider, not the nephrologist, is often the real defendant.

The single highest-value pattern is the fatal potassium: a critical lab that was returned, where the urgent intervention — dialysis or aggressive medical management — was deferred. That is a closed-loop failure on the most time-sensitive value in the specialty, and it should immediately raise both plaintiff merit and defense risk.

The Contributing Factors That Drive Payouts

The reported nephrology contributing factors follow the cross-cutting pattern, with lab follow-up especially central given how lab-driven the specialty is:

• Clinical-judgment and patient-assessment failures — inadequate workup and evaluation. In the internal-medicine analogue data, a substantial share of diagnosis claims trace to the patient-evaluation step, and a majority involve testing failures — ordering, interpreting, or acting on results.
• Communication failures — provider-to-provider handoffs (primary care to nephrology), provider-to-patient (consent on dialysis access and its risks), and the failure to communicate a critical lab value.
• Failure to monitor or follow up on abnormal results — labs and declining renal function. In a lab-driven specialty, the closed-loop failure on a critical value is the defining systemic signal.
• Technical and performance skill — procedural error in CVC and access placement, reported as the most common error type in dialysis-access disputes.
• Documentation gaps — incomplete records supporting the decision-making and informed consent (no nephrology-specific percentage was available in the source data).

The defining nephrology question is whether the critical value was acted on. A documented escalation — recognized hyperkalemia, urgent treatment ordered, dialysis arranged — is a strong defense. A critical potassium that returned and sat is the plaintiff's case.

What Separates a Strong Case From a Weak One

The strong plaintiff case

• A critical lab — most often hyperkalemia — that was returned and not acted on, where urgent dialysis or aggressive management was available and deferred, ending in a fatal or catastrophic outcome.
• A clear closed-loop failure on a time-sensitive value, with the nephrologist demonstrably owning the decision.
• A vascular-access or CVC complication that reflects a negligent technical error rather than a disclosed, known risk.
• A causation story that survives scrutiny — the deferred intervention, not the underlying disease, drove the death.

The strong defense case

• Documented recognition and escalation of the critical value — the right call was made and the chart shows it.
• The co-defendant defense: the decision at issue belonged to the hospitalist, intensivist, or primary-care physician, and the nephrologist was named reflexively for an upstream error.
• A vascular-access complication that was a disclosed, recognized risk, managed appropriately.
• Causation: the patient's underlying renal and cardiac disease, not the timing of dialysis, drove the outcome — a frequent and strong defense given how sick these patients typically are.

The weak case on either side ignores who owned the decision and what the labs showed. A plaintiff theory that names the nephrologist for an upstream failure, or that treats a catastrophic outcome in a critically ill ESRD patient as automatic negligence, will struggle on both attribution and causation. A defense that leans on the patient's comorbidities while a critical potassium sat unaddressed will not hold. And given the thin underlying data, both sides should anchor on the contemporaneous record rather than on specialty-wide statistics.

Bottom Line

Nephrology is low-frequency, high-severity, and thin on data — a combination that demands caution. The defining claim is the delayed or withheld dialysis that ends in fatal hyperkalemia, followed by missed AKI and dialysis-access complications. These cases turn on whether the critical value was acted on, whether the nephrologist actually owned the decision (versus being a reflexive co-defendant), and whether the deferred intervention rather than the underlying disease drove the outcome. Screen for the closed-loop failure on the critical lab, scrutinize attribution, and confirm the causation expert early — and weight the inferred statistics accordingly.

For how damages exposure varies across jurisdictions, see our medical malpractice damages-by-state tool, and if a pre-suit expert filing is required, run the certificate of merit readiness checker before drafting.

Questions? Contact us at [email protected] or (856) 979-6525

🔎 Screening a case in a different specialty? Browse all 70 specialty malpractice-risk guides in one place — Why Doctors Get Sued: Malpractice Risk by Specialty →